Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT07479472

A Prospective Observational Study on of Early-Onset Gastrointestinal Cancer: From Tumor Features to Patient Lifestyle Habits

A Prospective Observational Study on of Early-Onset Gastrointestinal Cancer: From Tumor Features to Patient Lifestyle Habits - YOGICO Study

Status
Not Yet Recruiting
Phase
Study type
Observational
Enrollment
150 (estimated)
Sponsor
Gruppo Oncologico Italiano di Ricerca Clinica · Academic / Other
Sex
All
Age
18 Years – 49 Years
Healthy volunteers
Not accepted

Summary

The YOGICO study aims to characterize the distinctive features of EoGI cancer through a holistic approach that integrates clinical and demographic data, tumor biological characteristics, and patient lifestyle habits

Detailed description

This is an observational, prospective multicenter study to characterize newly diagnosed EoGI cancer patients from a holistic approach, covering aspects from tumor features to patient lifestyle habits. Since this is a prospective observational study, participation does not alter any cancer treatments that patients will undergo after their cancer diagnosis, as per best clinical practice at each participating center. The number of patients included in the study will range from 150 to 200, enrolled in national centers located in northern Italy, as well as in diverse hospital settings (e.g., small vs. large hospitals).

Conditions

Interventions

TypeNameDescription
OTHERto characterize the distinctive features of EO-GI cancer through a comprehensive approach that considers clinical and demographic factors, tumor features, and patient lifestyle habitsto characterize the distinctive features of EO-GI cancer through a comprehensive approach that considers clinical and demographic factors, tumor features, and patient lifestyle habits, in a real-world Italian settings, mainly located in Northern Italy

Timeline

Start date
2026-04-01
Primary completion
2028-04-01
Completion
2028-04-01
First posted
2026-03-18
Last updated
2026-03-18

Locations

11 sites across 1 country: Italy

Source: ClinicalTrials.gov record NCT07479472. Inclusion in this directory is not an endorsement.